Effective September 26, 2017, the Board of Directors (the “Board”) of Sorrento Therapeutics, Inc. (Nasdaq: SRNE) appointed each of Dorman Followwill and David Lemus as an independent director of the Company.
{iframe}http://markets.businessinsider.com/news/stocks/Sorrento-Therapeutics-Appoints-Mr-Dorman-Followwill-And-Mr-Dave-Lemus-To-The-Board-Of-Directors-1002914380{/iframe}